Pohl A, Moser K, Micksche M
Wien Klin Wochenschr. 1981 Jul 10;93(14):439-57.
Interferons are soluble cellular products secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. In viral infections, interferon controls the spread of viruses by inhibiting viral protein synthesis and/or nucleic acid replication and by activating cellular immune responses which effectively eliminate virus-infected cells. Immune interferon, produced in a cellular immune response as the result of an infection, tumour, or hypersensitivity reaction, governs the local immune response to the abrogation of that tumour or other injury by directly reducing cell multiplication and recruiting cytotoxic cells. Clinical trials have shown some effectiveness of interferon in the treatment of chronic viral infections as well as some possible antitumour effects. Because of the extreme scarcity of human interferon and the use of highly impure preparations, the results to date are not conclusive. Therapeutic effectiveness rather than prophylactic effects, has still to be proved by controlled clinical studies with purified interferon under economically feasible conditions.
干扰素是脊椎动物细胞分泌的可溶性细胞产物,可对多种诱导物作出反应。它们赋予机体抵抗多种不同病毒的能力,抑制正常细胞和恶性细胞的增殖,阻碍细胞内寄生虫的繁殖,增强巨噬细胞和粒细胞的吞噬作用,提高自然杀伤细胞的活性,并表现出其他几种免疫调节功能。在病毒感染中,干扰素通过抑制病毒蛋白质合成和/或核酸复制以及激活细胞免疫反应来控制病毒的传播,而细胞免疫反应可有效清除病毒感染的细胞。免疫干扰素是在感染、肿瘤或过敏反应引起的细胞免疫反应中产生的,它通过直接减少细胞增殖和募集细胞毒性细胞来控制对肿瘤或其他损伤消除的局部免疫反应。临床试验表明,干扰素在治疗慢性病毒感染方面有一定疗效,也可能有一些抗肿瘤作用。由于人干扰素极其稀少且使用的制剂纯度极低,迄今为止的结果尚无定论。在经济可行的条件下,使用纯化干扰素进行对照临床研究,仍有待证明其治疗效果而非预防效果。